New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Latest Sun Pharma News & Updates
Mumbai, March 2 (IANS) Indian stock markets closed sharply lower on Monday as rising tensions between the US and Iran dampened investor sentiment and triggered selling across sectors.The benchmark Nifty fell 1.24 per cent, or 312.95 points, to settle at 24,865.70. The Sensex dropped 1.29 per cent, or 1,048.34 points, to close at 80,238.85, marking its lowest level since September 2025.Although the indices recovered some losses from the day’s lows, they remained firmly in the red by the end of …
Mumbai, Feb 26 (IANS) The Indian stock market ended a volatile trading session on a mixed note on Thursday, with healthcare and PSU bank stocks leading the gains while media and FMCG shares lagged behind.The benchmark Nifty closed marginally higher by 0.06 per cent, or 14.05 points, at 25,496.55. In contrast, the Sensex slipped 27.46 points, or 0.03 per cent, to settle at 82,248.61.Commenting on Nifty technical outlook, experts said that a decisive close above 25,700 accompanied by strong volume…
Mumbai, Feb 25 (IANS) Indian stock markets ended slightly higher on Wednesday, even though they gave up most of their early gains during the day. Heavyweights like Reliance Industries and State Bank of India put pressure on the indices, while buying in metal and IT stocks helped limit the losses.The Nifty closed 57.85 points, or 0.23 per cent, higher at 25,482.50. The Sensex ended up 50.15 points, or 0.06 per cent, at 82,276.07.Analysts said that the 25,400 level is acting as immediate structura…
Mumbai, Jan 28 (IANS) Indian equity benchmark indices Sensex and Nifty ended Wednesday’s session with modest gains, managing to stay in the green despite sharp volatility through the day. Investor sentiment was influenced by December-quarter earnings announcements and the finalisation of the India–European Union Free Trade Agreement.The Sensex closed at 82,345, rising 487 points, or 0.60 per cent. During the session, the index moved between a high of 82,504 and a low of 81,815 as markets swu…
New Delhi, Jan 26 (IANS) Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).In its Enforcement Report, the US health regulator said the US-based arm of Mumbai-headquartered Sun Pharma is recalling more than 26,000 bottles of a generic medicine used to treat dandruff and skin conditions that cause inflammation and itching.Sun…
Mumbai, Jan 20 (IANS) The Indian stock market extended its losses on Tuesday, ending the session sharply lower as investors remained cautious amid rising global tensions and continued to react to company-specific developments during the ongoing Q3 earnings season.Benchmark indices witnessed heavy selling throughout the day. The Sensex closed at 82,180.47, down 1,065.71 points or 1.28 per cent.Meanwhile, the Nifty settled at 25,232.5, slipping 353 points or 1.38 per cent by the end of the session…
Mumbai, Jan 7 (IANS) Indian equity markets ended lower for the third consecutive session on Wednesday as ongoing geopolitical tensions kept investors on edge and selling pressure in automobile and oil marketing company stocks weighed on overall sentiment.At the close of trade, the Sensex slipped 102.20 points, or 0.12 per cent, to settle at 84,961.14. The Nifty also closed in the red, falling 37.95 points, or 0.14 per cent, to end at 26,140.75.“A sustained move above 26,300 would be required t…
Mumbai, Dec 31 (IANS) Indian equity markets ended the final trading session of the calendar year on a strong note, supported by broad-based buying across most sectors, even as information technology stocks remained under pressure.At the close of trade, the Sensex settled at 85,220.6, gaining 545.52 points or 0.64 per cent.The Nifty also finished higher at 26,129.6, up 190.75 points or 0.74 per cent. “Holding above the 26,000 mark remains crucial to sustain the ongoing uptrend and keep the poss…
New Delhi, Dec 26 (IANS) From changing the definition to the rise of GLP-1 medications, and the government’s several initiatives, especially Prime Minister Narendra Modi’s clarion call, obesity became the focus of healthcare in India in 2025.The anti-obesity drive, especially the generic drugs, will continue to remain a key focus in 2026.Traditionally, Body Mass Index (BMI) was used to define obesity, but after 15 long years, India revamped its obesity guidelines in 2025 by lowering the thresh…